Tianshui Zhongxing Bio-technology Co.,Ltd.

Tianshui Zhongxing Bio-technology Co.,Ltd.

002772.SZ
Tianshui Zhongxing Bio-technology Co.,Ltd.CN flagShenzhen Stock Exchange
13.11
CNY
-0.77
- -
4.91BMarket Cap
Tianshui Zhongxing Bio-technology Co.,Ltd.
002772.SZ
(Shenzhen Stock Exchange)

Recent

price

13.11

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
0.86
1.15
1.67
1.79
1.81
2.03
2.57
3.21
4.4
3.96
4.98
4.74
4.94
5.6
5.14
Revenue per Share
- -
0.29
0.24
0.39
0.43
0.49
0.39
0.31
0.19
0.56
0.14
0.4
0.39
0.33
0.89
0.45
Basic EPS, GAAP
- -
-0.62
-0.34
-0.09
0.09
-0.76
-0.81
-1.16
-0.85
0.03
-1.78
0.63
0.97
0.64
-0.15
-0.86
Free Cash Flow per Basic Share
- -
0.11
0.07
0.11
0.13
0.1
0.15
0.14
0.22
0.31
0.38
0.43
0.52
0.51
0.5
0.5
Dividend per Share
- -
0.81
1.01
1.39
1.71
2.54
2.53
2.76
2.84
3.47
3.12
3.38
3.32
3.45
4.14
3.48
Book Value per Share
- -
1.15
1.26
1.63
3.26
6.42
6.58
6.48
6.31
7.09
7.39
7.68
7.61
7.6
8.47
7.75
Tangible Book Value per Share
- -
222
229
230
267
323
365
361
360
337
393
396
408
392
375
375
Basic Weighted Avg Shares
131
190
264
383
480
585
740
926
1,156
1,483
1,556
1,970
1,931
1,935
2,098
1,928
Sales/Revenue/Turnover
35.06
32.58
19.93
23.65
23.53
23.07
13.47
9.7
11.29
15.12
6.46
13.73
10.82
8.29
16.76
9.13
Operating Margin (%)
- -
21
35
43
55
68
91
143
191
224
257
275
269
287
315
- -
Depreciation Expense
44
64
55
91
114
159
142
112
68
189
55
158
160
128
335
168
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.36
- -
Effective Tax Rate (%)
33.18
33.61
20.74
23.7
23.85
27.09
19.23
12.08
5.92
12.74
3.53
8.04
8.26
6.62
15.96
8.69
Profit Margin (%)
26
71
151
212
254
1,208
1,643
1,045
1,416
1,362
2,259
1,593
1,199
1,116
1,971
1,511
Working Capital
48
126
292
386
298
463
1,052
1,029
1,864
1,855
2,331
1,622
1,075
1,060
1,969
1,587
LT Debt
181
351
407
498
1,038
2,292
2,635
2,632
2,602
2,732
3,251
3,385
3,436
3,319
3,534
3,257
Total Equity
- -
16.42
8.56
10.86
9.65
6.48
3.06
2.4
3.12
4.58
1.8
4.51
3.63
2.86
5.79
3.02
Return on Invested Capital (%)
- -
29.35
13.15
15.24
16.21
15.05
8.62
6.39
5.53
8.23
3.59
6.26
6.59
5.76
9.59
6.17
Return on Capital (%)
- -
55.65
26.53
32.9
29.39
24.78
16.32
11.67
6.78
17.24
4.58
12.34
11.86
9.47
23.06
13.03
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
1,310
1,102
1,104
LT Borrowings
1,059
1,453
1,586
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
393
393
393
Market Capitalization
2,897
2,695
2,932

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
2,830
3,035
3,035
Cash, Cash Equivalents & STI
1,517
1,712
1,637
Accounts Receivable, Net
36
39
36
Inventories
1,252
1,258
1,324
Total Current Liabilities
1,714
1,469
1,524
Payables & Accruals
- -
- -
- -
ST Debt
1,310
1,102
1,104
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.73%
5.54%
6.49%
Free Cash Flow
-885.16%
-1,529.39%
-122.28%
Net Income, GAAP
40.42%
51.96%
161.63%
Sales/Revenue/Turnover
16.5%
7.64%
8.43%
Total Cash Common Dividend
21.31%
14%
-6.28%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
487
428
502
519
1,935
2025
473
435
623
- -
2,098
2026
602
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
- -
- -
- -
0.33
2025
0.13
- -
- -
- -
0.89
2026
0.43
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
- -
- -
- -
0.51
2025
0.04
- -
- -
- -
0.5
2026
0.2
- -
- -
- -
- -
Business
Tianshui Zhongxing Bio-technology Co.,Ltd. Tianshui Zhongxing Bio-technology Co.,Ltd. is a China-based company principally engaged in the research, development, factory cultivation, and sale of edible fungi products. The company offers flammulina velutipes (enoki mushrooms) under brands including Xihuang, Nuwa, Xuebai, and Junfu; agaricus bisporus (bisporus mushrooms) under the Zhongxing brand; and cordyceps sinensis mushrooms, along with related packaging solutions; it also pursues agriculture planting, investment management, and real estate development activities. Founded in 2005 and headquartered in Tianshui, Gansu Province, the company follows a global production strategy centered in northwest China while expanding domestically and internationally, targeting consumers with green, safe, high-quality fungus products backed by modern biotechnology. In recent developments, Tianshui Zhongxing unveiled a 2025 Stock Option Incentive Plan, adjusted its equity structure in subsidiary Sichuan Zhongxing Bio-technology Co., Ltd. to hold 71% ownership while allocating 29% to management and technical personnel, and plans to invest 700 million yuan in the Southwest Headquarters Base Project for the edible and medicinal mushroom industry in partnership with Jintang County authorities; additionally, it implemented a 2024 dividend of 3 yuan per 10 shares.